Taiwan · Delayed Price · Currency is TWD TCM Biotech International Statistics
Total Valuation
TPEX:4169 has a market cap or net worth of TWD 10.54 billion. The enterprise value is 10.03 billion.
| Market Cap | 10.54B |
| Enterprise Value | 10.03B |
Important Dates
The next estimated earnings date is Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4169 has 59.05 million shares outstanding. The number of shares has increased by 2.65% in one year.
| Current Share Class | 59.05M |
| Shares Outstanding | 59.05M |
| Shares Change (YoY) | +2.65% |
| Shares Change (QoQ) | +5.80% |
| Owned by Insiders (%) | 21.19% |
| Owned by Institutions (%) | n/a |
| Float | 38.06M |
Valuation Ratios
The trailing PE ratio is 549.83.
| PE Ratio | 549.83 |
| Forward PE | n/a |
| PS Ratio | 15.38 |
| PB Ratio | 9.99 |
| P/TBV Ratio | 10.16 |
| P/FCF Ratio | 304.23 |
| P/OCF Ratio | 283.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 234.03, with an EV/FCF ratio of 289.47.
| EV / Earnings | 523.15 |
| EV / Sales | 14.63 |
| EV / EBITDA | 234.03 |
| EV / EBIT | n/a |
| EV / FCF | 289.47 |
Financial Position
The company has a current ratio of 7.47, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.47 |
| Quick Ratio | 6.06 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 0.97 |
| Interest Coverage | 21.59 |
Financial Efficiency
Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 1.81% |
| Return on Assets (ROA) | 0.98% |
| Return on Invested Capital (ROIC) | 2.85% |
| Return on Capital Employed (ROCE) | 1.71% |
| Weighted Average Cost of Capital (WACC) | 4.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.72 |
Taxes
In the past 12 months, TPEX:4169 has paid 3.13 million in taxes.
| Income Tax | 3.13M |
| Effective Tax Rate | 14.03% |
Stock Price Statistics
The stock price has increased by +215.14% in the last 52 weeks. The beta is 0.04, so TPEX:4169's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +215.14% |
| 50-Day Moving Average | 190.77 |
| 200-Day Moving Average | 133.30 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 422,572 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4169 had revenue of TWD 685.49 million and earned 19.17 million in profits. Earnings per share was 0.32.
| Revenue | 685.49M |
| Gross Profit | 316.99M |
| Operating Income | 18.65M |
| Pretax Income | 22.30M |
| Net Income | 19.17M |
| EBITDA | 42.85M |
| EBIT | 18.65M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 545.07 million in cash and 33.75 million in debt, with a net cash position of 511.32 million or 8.66 per share.
| Cash & Cash Equivalents | 545.07M |
| Total Debt | 33.75M |
| Net Cash | 511.32M |
| Net Cash Per Share | 8.66 |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 16.89 |
| Working Capital | 743.57M |
Cash Flow
In the last 12 months, operating cash flow was 37.13 million and capital expenditures -2.49 million, giving a free cash flow of 34.65 million.
| Operating Cash Flow | 37.13M |
| Capital Expenditures | -2.49M |
| Depreciation & Amortization | 24.20M |
| Net Borrowing | -7.37M |
| Free Cash Flow | 34.65M |
| FCF Per Share | 0.59 |
Margins
Gross margin is 46.24%, with operating and profit margins of 2.72% and 2.80%.
| Gross Margin | 46.24% |
| Operating Margin | 2.72% |
| Pretax Margin | 3.25% |
| Profit Margin | 2.80% |
| EBITDA Margin | 6.25% |
| EBIT Margin | 2.72% |
| FCF Margin | 5.05% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | 22.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 107.81% |
| Buyback Yield | -2.65% |
| Shareholder Yield | -2.46% |
| Earnings Yield | 0.18% |
| FCF Yield | 0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2023. It was a forward split with a ratio of 1.0306.
| Last Split Date | Jul 20, 2023 |
| Split Type | Forward |
| Split Ratio | 1.0306 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |